Platelets: New players in the mucosal scenario of inflammatory bowel disease

European Review for Medical and Pharmacological Sciences

Volumn 8, Issue 5, 2004, Pages 193-198

  Danese, S ^a   Scaldaferri, F ^a   Papa, A ^a   Pola, R ^a   Sans, M ^b   Gasbarrini, G ^a   Pola, P ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Endothelium; Platelets

Indexed keywords

ARTICLE; CELL ACTIVATION; CROHN DISEASE; ENDOTHELIUM CELL; ENTERITIS; HEMOSTASIS; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY CELL; INTESTINE MUCOSA; MICROVASCULARIZATION; MUCOSA INFLAMMATION; THROMBOCYTE FUNCTION; TISSUE INJURY; ULCERATIVE COLITIS;

BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA;

EID: 10644294704     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
2. Fiocchi C. Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 1997; 273: G769-G775.
3. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996; 39: 1781-1790.
4. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-242.
5. Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000; 97: 6930-6932.
6. Collins CE, Rampton DS. Platelet in inflammatory bowel disease - pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997; 11: 237-247.
7. Stevens TRJ, James JP, Simmonds NJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut 1992; 33: 502-506.
8. Thompson NP, Wakefield AJ, Pounder RE. Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108: 1011-1015.
9. Korzenik JR. IBD. A vascular disorder? The case for heparin therapy. Inflamm Bowel Dis 1997; 3: 87-94.
10. Wakefield AJ, Dhillon AP, Rowles PM, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-1062.
11. Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in Crohn's disease. Gut 1993; 34: 375-81.
12. Page C. Platelets as inflammatory cells. Immunopharmacology 1989; 17: 51-59.
13. Klinger MH. Platelets and inflammation. Anat Embryol (Berl) 1997; 196: 1-11.
14. Aukrust P, Waehre T, Damas JK, et al. Inflammatory role of platelets in acute coronary syndromes. Heart 2001; 86: 605-606.
15. Weyrich AS, Prescott SM, Zimmerman GA. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation 2002; 106: 1433-1435.
16. Grewal IS, Flavell RA. CD40 and CD154 on cell-mediated immunity. Annu Rev Immunol 1998; 16: 111-135.
17. vanKooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2-17.
18. Biancone L, Cantaluppi V, Camussi G. CD40-CD154 interaction in experimental and human disease. Int J Mol Med 1999; 3: 343-353.
19. Slupsky JR, Kalbas M, Willuweit A, et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998; 80: 1008-1014.
20. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20: 2322-2328.
21. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-490.
22. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-1534.
23. Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628-635.
24. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 1991; 174: 785-790.
25. Kaplanski G, Porat R, Aiura K, et al. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 1993; 81: 2492-2495.
26. Gawaz M, Neumann F-J, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998; 98: 1164-1171.
27. Slupsky JR, Kalbas M, Willuweit A, et al. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998; 80: 1008-1014.
28. Xu H, Arnaud F, Tadaki DK, et al. Human platelets activate porcine endothelial cells through a CD154-dependent pathway. Transplantation 2001; 72: 1858-1861.
29. Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syndrome express enhanced CD40 ligand/CD154 on platelets. Heart 2001; 86: 649-655.
30. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594.
31. Nagahama M, Nomura S, Ozaki Y, et al. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 2001; 33: 85-94.
32. Endresen GK. Evidence for activation of platelets in the synovial fluid from pateints with rheumatoid arthritis. Rheumatol Int 1989; 9: 19-24.
33. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 2001; 357: 2023-2024.
34. Koutrobakis IE. Role of thrombotic risk factors in inflammatory bowel disease. Dig Dis 2000; 18: 161-167.
35. Collins CE, Rampton DS. Platelet in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997; 11: 237-247.
36. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106: 840-845.
37. Tschoepe D, Schwippert B, Schumacher B, et al. Increased P-selectin (CD62) expression on platelets from capillary whole blood of patients with Crohn's disease. Gastroenterology 1993; 104: A793.
38. Schaufelberger HD, Uhr MR, McGukin C, et al. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest 1994; 24: 656-663.
39. Carty E, Macey M, Rampton DS. Inhibition of platelets activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14: 1169-1179.
40. Danese S, De La Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of Inflammatory bowel disease patients. Gastroenterology 2003; 124: 1249-1264.
41. Danese S, Katz J, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of Inflammatory bowel disease patients. Gut 2003; 52: 1435-1441.
42. Dhillon AP, Anthony A, Sim R, et al. Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21: 127-133.
43. More L, Sim R, Hudson M, et al. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol 1993; 46: 703-708.
44. Sankey EA, Dhillon AP, Anthony A, et al. Early mucosal changes in Crohn's disease. Gut 1993; 34: 375-381.
45. Saadi S, Wrenshall LE, Platt JL. Regional manifestations and control of the immune system. FASEB J 2002; 16: 849-856.
46. Collins CE, Rampton DS, Rogers J, et al. Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 1213-1217.
47. Vogel JD WG, Sturm A, Levine AD, et al. Essential role of the CD40 pathway in T-cell-mediated induction of chemokines and cell adhesion molecules by human intestinal fibroblasts and microvascular endothelial cells. Gastroenterology 2001; 120: A192.
48. Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994; 179: 1689-1694.
49. Russell J, Cooper D, Tailor A, et al. Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am J Physiol Gastrointest Liver Physiol 2003; 284: G123-G129.
50. Suzuki K, Sugimura K, Hasegawa K, et al. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol 2001; 36: 1301-1306.
51. Kruidenier L, Verspaget HW. Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment Pharmacol Ther 2002; 16: 1997-2015.
52. Danese S, De La Motte C, Reyes BM, et al. Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol. 2004; 172: 2011-2015.
53. Collins CE, Rampton DS. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 1995; 36: 5-8.
54. Collins CE, Rampton DS. Review article: platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment Pharmacol Ther 1997; 11: 237-247.
55. Danese S, De La Motte C, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications. Am J Gastroenterol. 2004; 99: 938-945.